SAPIEN THERAPEUTICS

Serial Number 78235433
606

Registration Progress

Application Filed
Apr 8, 2003
Under Examination
Apr 19, 2005
Approved for Publication
Jan 5, 2005
Published for Opposition
Jan 25, 2005
Registered

Trademark Image

SAPIEN THERAPEUTICS

Basic Information

Serial Number
78235433
Filing Date
April 8, 2003
Published for Opposition
January 25, 2005
Abandonment Date
April 20, 2007
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 20, 2007
Classes
005

Rights Holder

Edwards Lifesciences Corporation

03
Address
One Edwards Way
Irvine, CA 92614

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Edwards Lifesciences Corporation

Original Applicant
03
Irvine, CA

Edwards Lifesciences Corporation

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Debra D. Condino

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description
Jun 20, 2007 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 20, 2007 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 20, 2007 EXPT T EXPARTE APPEAL TERMINATED
Oct 19, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2006 EXT3 S SOU EXTENSION 3 FILED
Oct 19, 2006 EX3G S SOU EXTENSION 3 GRANTED
Apr 14, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 14, 2006 EXT2 S SOU EXTENSION 2 FILED
Apr 14, 2006 EX2G S SOU EXTENSION 2 GRANTED
Oct 18, 2005 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 18, 2005 EXT1 S SOU EXTENSION 1 FILED
Oct 18, 2005 EX1G S SOU EXTENSION 1 GRANTED
Apr 19, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2005 PUBO A PUBLISHED FOR OPPOSITION
Jan 5, 2005 NPUB O NOTICE OF PUBLICATION
Nov 23, 2004 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 19, 2004 ALIE A ASSIGNED TO LIE
Nov 18, 2004 CNEA R EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2004 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2004 CNEA O EXAMINERS AMENDMENT MAILED
Oct 18, 2004 EXAF T EXPARTE APPEAL RECEIVED AT TTAB
Oct 18, 2004 EXPI T EX PARTE APPEAL-INSTITUTED
Apr 19, 2004 CNFR O FINAL REFUSAL MAILED
Apr 5, 2004 DOCK D ASSIGNED TO EXAMINER
Mar 5, 2004 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2004 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2003 CNRT F NON-FINAL ACTION MAILED
Sep 14, 2003 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
Therapeutics for the treatment of cardio-vascular disease, nemly, nucleic acid and protein therapeutics that promote angiogenesis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"therapeutics"

USPTO Documents

Loading USPTO documents...